Scienture Holdings, Inc. (SCNX) — 10-K Filings
All 10-K filings from Scienture Holdings, Inc.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
Scienture Launches First Product, Faces 'Going Concern' Doubt
— Mar 30, 2026 Risk: high
Scienture Holdings, Inc. (SCNX) is a clinical-stage biopharmaceutical company that became a wholly-owned subsidiary in July 2024, focusing on cardiovascular (CV -
Scienture Holdings, Inc. Files 2024 10-K
— Mar 26, 2025 Risk: medium
Scienture Holdings, Inc. filed its 2024 10-K on March 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as TRxADE HEA -
TRxADE HEALTH, INC. Files 10-K for Fiscal Year Ended December 31, 2023
— Apr 22, 2024 Risk: medium
TRxADE HEALTH, INC (SCNX) filed a Annual Report (10-K) with the SEC on April 22, 2024. TRxADE HEALTH, INC. filed its annual 10-K report for the fiscal year endi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX